Showing results (671-680 of 689) with videos related to

Sort By:
Pageof 69
Blood|January 15, 2016
Postibrutinib outcomes in patients with mantle cell lymphomaPeter Martin, Kami Maddocks, John P Leonard, et al.
Journal of Health Organization and Management|October 5, 2016
Leadership and management in UK medical school curriculaRichard Jefferies, Ibrahim H N Sheriff, Jacob H Matthews, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 5, 2020
Addressing Nanomaterial Immunosafety by Evaluating Innate Immunity across Living SpeciesDiana Boraschi, Andi Alijagic, Manon Auguste, et al.
Integrated Environmental Assessment and Management|September 10, 2020
Mechanistic Effect Modeling of Earthworms in the Context of Pesticide Risk Assessment: Synthesis of the FORESEE WorkshopValery E Forbes, Annika Agatz, Roman Ashauer, et al.
NEJM Evidence|February 6, 2024
Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid CancersMichael L Wang, Jacqueline C Barrientos, Richard R Furman, et al.
Blood Advances|December 14, 2022
Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemiaChaitra Ujjani, Ted A Gooley, Stephen E Spurgeon, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunityEmily E Steffke, Laila Latifi, Taijun Hana, et al.
The New England Journal of Medicine|June 21, 2013
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphomaMichael L Wang, Simon Rule, Peter Martin, et al.
The New England Journal of Medicine|June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Blood Advances|February 5, 2024
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective studyLaura Samples, Jenna Voutsinas, Bita Fakhri, et al.
Pageof 69